Biomarker Expertise BioCytex specializes in biomarker detection and flow cytometry across normal and pathological cells in whole blood, bone marrow, and tissues, making them a strong partner for pharma companies needing robust assay development and validation capabilities.

Preclinical to Phase III With experience spanning preclinical investigations through pharmacodynamic clinical studies up to Phase III trials, BioCytex can support sponsors across multiple development stages, presenting cross-stage service opportunities and long-term collaborations.

High-Throughput Cytometry The ability to measure hundreds of cells per second across multiple parameters positions BioCytex as a scalable CRO for complex immunophenotyping, intracellular/extracellular marker detection, and multiplex assay development for diverse therapeutic programs.

Collaborative Network Existing engagement with worldwide pharmaceutical companies suggests readiness for expanded partnerships, potential for preferred vendor status, and opportunities to upsell additional assay validation, regulatory support, or translational studies.

Tech-Driven Efficiency Utilizing a modern tech stack including AWS, content management platforms, and analytics tools signals potential for offering cloud-enabled data management, secure data delivery, and scalable reporting solutions to pharma clients.